|
|
|
Outcome of shared decision-making in a patient with primary herpes gingivostomatitis during pregnancy: a case report |
C.Y. Huang1, T.C. Chao1, H.C. Chien2, Y.L. Liu1, 3, 4, 5, *( ) |
1Department of Obstetrics and Gynecology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan 2Department of Physiology and Biophysics, National Defense Medical Center, Taipei, Taiwan 3Center for Reproductive Medicine, Taipei Medical University Hospital, Taipei, Taiwan 4Division of Infertility, Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan 5Department of Obstetrics and Gynecology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan |
|
|
Abstract Purpose: The authors present the case of a woman in the 20th week of pregnancy with herpes simplex virus (HSV)-related gingivostomatitis. They also provide information regarding the benefits and risks of acyclovir, valacyclovir, famciclovir, and shared decision-making (SDM) through which valacyclovir was selected. Case Report: A 26-year-old primigravida woman who denied having a history of systemic diseases presented with fever, general malaise, and abdominal pain at 20 weeks of gestation. As no strong evidence supports any current treatment for primary maternal HSV-1 gingivostomatitis during pregnancy, the authors used three key steps of SDM, namely choice talk, option talk, and decision talk, to help the patient make a decision based on the benefits and ill-effects of treatment with acyclovir, valacyclovir, and famciclovir. Valacyclovir was administered for one week. Her general condition improved gradually, and the symptoms abated without recurrence of fever. Conclusions: Thus, SDM-based treatment was effective in this patient.
|
Submitted: 20 June 2019
Accepted: 24 September 2019
Published: 15 August 2020
|
Fund: MOST 106-2314-B-016-004/Ministry of Science and Technology, Taiwan, ROC;MOST 107-2314-B-016-065-MY2/Ministry of Science and Technology, Taiwan, ROC;TSGH-C106-081/ Tri-Service General Hospital;TSGH-C107-082/Tri-Service General Hospital;TSGH-C108-116/Tri-Service General Hospital;TSGH-PH-105-4/Tri-Service General Hospital, Penghu Branch |
*Corresponding Author(s):
Y.L. Liu
E-mail: h121976@yahoo.com.tw
|
[1] |
Anzivino E., Fioriti D., Mischitelli M., Bellizzi A., Barucca V., Chiarini F., et al.: “Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention”. Virol J, 2009, 6, 40.
doi: 10.1186/1743-422X-6-40
pmid: 19348670
|
[2] |
Kolokotronis A., Doumas S.: “Herpes simplex virus infection, with particular reference to the progression and complications of primary herpetic gingivostomatitis”. Clin Microbiol Infect, 2006, 12, 202-211.
doi: 10.1111/j.1469-0691.2005.01336.x
pmid: 16451405
|
[3] |
Elwyn G., Frosch D., Thomson R., Joseph-Williams N., Lloyd A., Kinnersley P., et al.: “Shared decision making: a model for clinical practice”. J Gen Intern Med, 2012, 27, 1361-1367.
doi: 10.1007/s11606-012-2077-6
|
[4] |
Chang Y.H., Tseng J.Y., Chen C.Y., Sung P.L., Yeh C.C., Yang M.J.: “Acyclovir-induced nephrotoxicity in a pregnant woman with chickenpox”. Taiwan J Obstet Gynecol, 2016, 55, 618-619.
doi: 10.1016/j.tjog.2016.06.012
pmid: 27590397
|
[5] |
Mercolini F., Verdi F., Eisendle K., Messner H., Staffler A.: “Congenital disseminated HSV-1 infection in preterm twins after primary gingivostomatitis of the mother: case report and review of the literature”. Z Geburtshilfe Neonatol, 2014, 218, 261-264.
doi: 10.1055/s-0034-1385854
pmid: 25518832
|
[6] |
Healy S.A., Mohan K.M., Melvin A.J., Wald A.: “Primary maternal herpes simplex virus-1 gingivostomatitis during pregnancy and neonatal herpes: Case series and literature review”. J Pediatric Infect Dis Soc, 2012, 1, 299-305.
doi: 10.1093/jpids/pis068
pmid: 26619423
|
[7] |
Pichler M., Staffler A., Bonometti N., Messner H., Deluca J., Thuile T., et al.: “Premature newborns with fatal intrauterine herpes simplex virus-1 infection: first report of twins and review of the literature”. J Eur Acad Dermatol Venereol, 2015, 29, 1216-1220.
doi: 10.1111/jdv.12583
pmid: 24909064
|
[8] |
Whitley R.J., Gnann J.W. Jr.: “Acyclovir: a decade later”. N Engl J Med, 1992, 327, 782-789.
doi: 10.1056/NEJM199209103271108
pmid: 1288525
|
[9] |
Perry C.M., Wagstaff A.J.: “Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections”. Drugs, 1995, 50, 396-415.
doi: 10.2165/00003495-199550020-00011
pmid: 8521764
|
[10] |
Kang S.H., Chua-Gocheco A., Bozzo P., Einarson A.: “Safety of antiviral medication for the treatment of herpes during pregnancy”. Can Fam Physician, 2011, 57, 427-428.
|
No Suggested Reading articles found! |
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|